Mammalian Target Rapamycin Inhibition for Proliferative Vitreoretinopathy copertina

Mammalian Target Rapamycin Inhibition for Proliferative Vitreoretinopathy

Mammalian Target Rapamycin Inhibition for Proliferative Vitreoretinopathy

Ascolta gratuitamente

Vedi i dettagli del titolo

3 mesi a soli 0,99 €/mese

Dopo 3 mesi, 9,99 €/mese. Si applicano termini e condizioni.

A proposito di questo titolo

Interview with Ehsan Rahimy, MD, author of Mammalian Target Rapamycin Inhibition as a Therapeutic Target for Prevention of Proliferative Vitreoretinopathy. Hosted by Neil Bressler, MD.

Related Content:

  • Mammalian Target Rapamycin Inhibition as a Therapeutic Target for Prevention of Proliferative Vitreoretinopathy
Ancora nessuna recensione